President - Jean Bellin
Jean Bellin has more than 30 years experience in the biopharmaceutical industry, including sales, marketing, business development, mergers and acquisitions, and general management - both domestic and international. He began his pharmaceutical industry career with 12 years at Eli Lilly & Company, holding positions in sales, marketing and general management in Brazil, the US, the Scandinavian countries and Italy. He then founded and served as Managing Director of DuPont Pharma Italy. In 1993, Mr. Bellin became the head of the international Pharmaceutical division of UCB, then a $2 billion publicly traded, biopharmaceutical and chemical group based in Brussels, Belgium. There he managed the pharmaceutical subsidiaries in the US, Canada, South America, Japan, China and Southeast Asia. Later he managed the Osteohealth and Animal Health global divisions of Luitpold Pharmaceuticals, a wholly-owned company of Sankyo Pharmaceuticals Company Ltd., then the second largest pharmaceutical company in Japan. In 2004 and 2005, he was the CEO of Mountain View Pharmaceuticals Inc., a California-based biopharmaceutical company where the PEGylation of therapeutic proteins was a major focus. In 2006, Jean became the President of Metagenics, a global life sciences company, where Mr. Bellin lead and grew the US and international sales, marketing and manufacturing operations of the company for 4 and a half years. Mr. Bellin left Metagenics in October of 2010 after its acquisition by the Alticor group, the $8.2 billion parent company of Nutrilite, the largest vitamin manufacturer in the world.
Mr. Bellin received his bachelor's degree in Economic, Political and Social Sciences from the Facultés Universitaires Saint Louis in Brussels and a License in Applied Economic Sciences from the Université Catholique de Louvain in Belgium.